Subject
Obstetrics and Gynecology,Oncology
Reference31 articles.
1. Recurrent epithelial ovarian cancer: an update on treatment;Foley;Oncology,2013
2. Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial;Pujade-Lauraine;Lancet Oncol.,2017
3. Niraparib maintenance therapy in platinum-sensitive, recurrent ovarian Cancer;Mirza;N. Engl. J. Med.,2016
4. Bevacizumab and paclitaxel-carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial;Coleman;Lancet Oncol.,2017
5. The impact of second to sixth line therapy on survival of relapsed ovarian cancer after primary taxane/platinum-based therapy;Hanker;Ann. Oncol.,2012